2016
DOI: 10.4103/0366-6999.172603
|View full text |Cite
|
Sign up to set email alerts
|

Novel Mutations in the 3β-hydroxy-Δ5-C27-steroid Dehydrogenase Gene (HSD3B7) in a Patient with Neonatal Cholestasis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
16
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(16 citation statements)
references
References 6 publications
(8 reference statements)
0
16
0
Order By: Relevance
“…As illustrated in Figure 2F, the region where rs1549293 resides was a potential enhancer as shown by its H3K4Me1 and H3K27Ac modification from ENCODE data [32].We then searched DNase I hypersensitive sites (DHSs), which showed possible transcription activities in the genome, across a total of 79 cell types [33]. In the genomic locus covering rs1549293, the chromosomal interactions with FUS and HSD3B7 were observed to form each of 54 kb and 145 kb complexes, suggesting a regulatory role by this SNP to these obesity-associated genes (Figure 2F, Pearson correlation coefficient r is 0.78 and 0.74, respectively) [34], [35]. Supporting evidence also came from the polymerase II chromatin interaction analysis with paired-end tag sequencing (ChIA-PET) data [36], which suggested that rs1549293 located in an enhancer that regulated the activities of both promoters of FUS and HSD3B7 .…”
Section: Resultsmentioning
confidence: 98%
“…As illustrated in Figure 2F, the region where rs1549293 resides was a potential enhancer as shown by its H3K4Me1 and H3K27Ac modification from ENCODE data [32].We then searched DNase I hypersensitive sites (DHSs), which showed possible transcription activities in the genome, across a total of 79 cell types [33]. In the genomic locus covering rs1549293, the chromosomal interactions with FUS and HSD3B7 were observed to form each of 54 kb and 145 kb complexes, suggesting a regulatory role by this SNP to these obesity-associated genes (Figure 2F, Pearson correlation coefficient r is 0.78 and 0.74, respectively) [34], [35]. Supporting evidence also came from the polymerase II chromatin interaction analysis with paired-end tag sequencing (ChIA-PET) data [36], which suggested that rs1549293 located in an enhancer that regulated the activities of both promoters of FUS and HSD3B7 .…”
Section: Resultsmentioning
confidence: 98%
“…Progressive intrahepatic cholestasis and neonatal cholestasis can be caused by several mutations in the HSD3B7 gene (54). Bile acid therapy is effective in treating HSD3B7deficient patients.…”
Section: Inborn Errors Of Bile Acid Metabolismmentioning
confidence: 99%
“…Among the prognostic differentially expressed mRNAs, HSD3B7 encodes an enzyme which is involved in the initial stages of the synthesis of bile acids from cholesterol and a member of the short-chain dehydrogenase/reductase superfamily [ 38 ]. Mutations in this gene are associated with a congenital bile acid synthesis defect which leads to neonatal cholestasis, but reduces the risk of late-onset Parkinson’s disease [ 39 , 40 ]. 7α25HC, an intermediate product of bile acid synthesis, is degraded by HSD3B7.…”
Section: Discussionmentioning
confidence: 99%